Skip to main content

Featured

The U.S. Is Banning Canadian Booze on Sept. 29 — Here's What It Means for Ontario's $1-Billion Industry

  LCBO shelves have been missing American bourbon and Napa wine since March 2025. In three weeks, the trade war flips direction — and this time it's Canadian producers, and the roughly 20,000 Ontarians who work for them, absorbing the hit. What's actually changing on Sept. 29 On Sept. 8, President Trump signed proclamations that ban a wide range of Canadian alcohol from entering the United States, effective 12:01 a.m. Eastern on Sept. 29. It's a different kind of measure than the tariffs Canadians have gotten used to reading about this year — this isn't a price increase, it's a door closed. Packaged beer, wine, cider, and spirits (including whisky, vodka, gin, rum, tequila and mezcal) are covered, alongside whey products, molasses, non-alcoholic beer, and larger motorcycles. Canadian alcohol previously imported but not yet cleared for consumption before Sept. 29 stays under the existing 50% duty instead of the outright ban. The White House's proclamation points ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment